Evidence map›Paper›PMID 24808534›Full record

ArticleAmerican journal of physiology. Renal physiology2014

First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.

Michael L Granda, Frederick A Schroeder, Ronald H J Borra, Nathan Schauer, Ehimen Aisaborhale, Alexander R Guimaraes, Jacob M Hooker

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antihypertensive mechanisms of intra-renal dopamine.Current opinion in nephrology and hypertension · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michael L GrandaAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and Eastern Virginia Medical School, Norfolk, Virginia.
Frederick A SchroederAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
Ronald H J BorraAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
Nathan SchauerAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
Ehimen AisaborhaleAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
Alexander R GuimaraesAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and.
Jacob M HookerAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; and hooker@nmr.mgh.harvard.edu.
Harvard University · USAthinoula A. Martinos Center for Biomedical Imaging · USMassachusetts General Hospital · US

Funding

Combined MRI/PET Imager for Simultaneous Acquisition of PET/MRI DataS10RR022976 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI JENKINS, BRUCE · 2007 to 2007
$2.0M
Inveon: A Triple Modality Biomedical Imaging SystemS10RR029495 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWNELL, ANNA-LIISA · 2010 to 2010
$1.3M
Validation of MRI Microvascular Biomarkers in Pancreatic Cancer with Magnetic NanoparticlesK08EB012859 · NIBIB · OREGON HEALTH & SCIENCE UNIVERSITY · PI GUIMARAES, ALEXANDER SAVIO RAMOS · 2011 to 2015
$875k
500 MHz NMR Spectrometer for Molecular Imaging ApplicationsS10RR023385 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2007 to 2007
$500k
Carbon-11 Radiopharmaceutical Production SystemS10RR026666 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWNELL, ANNA-LIISA · 2010 to 2010
$462k
NCRR NIH HHS S10 RR022976NCRR NIH HHS S10 RR023385NCRR NIH HHS S10 RR026666NCRR NIH HHS S10 RR029495NIBIB NIH HHS K08 EB012859
6 · The paper itself

Abstract

The intrarenal dopamine system is important for signaling and natriuresis, and significant dysfunction is associated with hypertension and kidney disease in ex vivo studies. Dopamine receptors also modulate and are modulated by the renin-angiotensin-aldosterone system. Here, we show the first in vivo measurement of D1-like receptors in the renal cortex of Sprague-Dawley rat and Papio anubis baboon using [(11)C]NNC 112, a positron emission tomography radioligand for D1-like receptors. In addition, we show a D1-like binding potential response to angiotensin II blockade in rats using losartan. Demonstration of self-saturable binding in the rat as well as specific and saturable binding in Papio anubis validate the use of [(11)C]NNC 112 in the first in vivo measurement of renal dopamine D1-like receptors. Furthermore, [(11)C]NNC 112 is a radioligand tool already validated for use in probing human central nervous system (CNS) D1-like receptors. Our work demonstrates specific and saturable non-CNS binding in higher animals and the ability to quantify physiological response to drug treatment and provides a clear path to extend use of [(11)C]NNC 112 to study renal dopamine in humans.

Indexed as

AnimalsBenzazepinesBenzofuransDisease Models, AnimalDopamineDopamine AntagonistsKidneyPapio anubisPositron-Emission TomographyRadioligand AssayRatsRats, Sprague-DawleyReceptors, Dopamine D1Renin-Angiotensin SystemBenzazepinesBenzofuransDopamineDopamine AntagonistsNNC 112Receptors, Dopamine D1SCH 23390dopaminehypertensionpositron emission tomographyrenal dopaminerenal PET

Identifiers

PMID24808534
PMCPMC4347741
OpenAlexW1965004765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.